The current hypertension guidelines recommend the use of angiotensin-converting enzyme inhibitors (ACEIs), angiotensin-II receptor blockers (ARBs), calcium-channel blockers (CCBs), diuretics (DIs), and β blockers (BBs) alone or in combination as first-line agents for hypertension and its complications, including stroke [4,5]. This evidence concerns the gene ACE and stroke disorder.